local
La FDA aprueba la primera vacuna contra la gripe basada en ARNm
Summary by The El Paso Editorial Desk CNN Newsource , as published by KVIA ABC-7
· August 6, 2026
· 1 min read
Photo: KVIA ABC-7 · view original
Story provenance No corrections
Summary created by The El Paso Editorial Desk — automated, rule-governed Byline on source page CNN Newsource, as published by KVIA ABC-7 Original story Read at the source Source published Aug 6, 2026 Indexed here Aug 6, 2026 AI assistance Automated summary drawn from the source’s own published text Prepublication human review No — editorial rules, flagged-item review, and published samples
Every story comes with a passport. How we work · Corrections log
Key takeaway It has been approved for use in adults 50 years of age or older.
The FDA has approved a new flu vaccine for adults 50 and older in the US. This vaccine is the first of its kind to be based on mRNA technology. It has been approved for use in adults 50 years of age or older.
The vaccine, developed by Moderna, has shown to be approximately 27% more effective than other options in a study of over 40,000 adults. Moderna's CEO views this approval as a significant step in addressing public health challenges through scientific innovation. Further details about the vaccine and its development are available from the source.
Why this matters
Local news anchors readers in their community — the people, places, and decisions that shape day-to-day life. The El Paso covers these stories because national outlets often won't.
About this story
As published by KVIA ABC-7 . The El Paso surfaces reporting from trusted publishers and adds local editorial context so readers can quickly understand what a story means for their community. We attribute every source, link to the original report, and follow a documented editorial standards policy. To understand how stories are selected and reviewed, read our about page .
For the complete original report, visit KVIA ABC-7 . Have a tip or correction? Contact our newsroom .
Category: local Published: August 6, 2026 Source: KVIA ABC-7 Reading time: 1 min
Frequently asked about this story
What is this story about? The FDA has approved a new flu vaccine for adults 50 and older in the US. This vaccine is the first of its kind to be based on mRNA technology. It has been approved for use in adults 50 years of age…
When was this published? This article was first published on August 6, 2026 by KVIA ABC-7 and curated for The El Paso readers.
Who reported this story? This story was reported by CNN Newsource at KVIA ABC-7. To learn more about how The El Paso selects and reviews stories, see our editorial standards .
Where can I find related coverage? See more local coverage from The El Paso, or browse our daily briefing and topic hubs .
← Back to all news
More local →
Today’s briefing
Subscribe to newsletter
